Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus that their body’s immune systems then see as foreign and mount responses against. mRNA vaccines, by contrast, include snippets of mRNA genetic material from the COVID-19 virus’ spike protein.

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

I had a COVID-19 vaccine in June 2023, so I’m overdue for another. I’ve heard there’s going to be an updated vaccine coming out in the fall. If

On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated versions of the Pfizer-BioNTech and Moderna vaccines. According to NPR, this latest vaccine is already being distributed and administered across the country.

The newly updated COVID-19 vaccine just arrived in pharmacies and clinics nationwide, and a new poll suggests nearly half of people age 50 and older plan to get it. But some older adults with high risk of severe illness appear unlikely to seek the vaccine,